company background image
PAA

PharmAust ASX:PAA Stock Report

Last Price

AU$0.069

Market Cap

AU$22.1m

7D

4.5%

1Y

-27.4%

Updated

06 Dec, 2022

Data

Company Financials
PAA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

PAA Stock Overview

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally.

PharmAust Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PharmAust
Historical stock prices
Current Share PriceAU$0.069
52 Week HighAU$0.12
52 Week LowAU$0.062
Beta0.64
1 Month Change-13.75%
3 Month Change-16.87%
1 Year Change-27.37%
3 Year Change-29.59%
5 Year Change40.82%
Change since IPO-99.23%

Recent News & Updates

Here's Why PharmAust Limited's (ASX:PAA) CEO Compensation Is The Least Of Shareholders Concerns

Nov 03
Here's Why PharmAust Limited's (ASX:PAA) CEO Compensation Is The Least Of Shareholders Concerns

Recent updates

Here's Why PharmAust Limited's (ASX:PAA) CEO Compensation Is The Least Of Shareholders Concerns

Nov 03
Here's Why PharmAust Limited's (ASX:PAA) CEO Compensation Is The Least Of Shareholders Concerns

Is PharmAust (ASX:PAA) In A Good Position To Deliver On Growth Plans?

May 30
Is PharmAust (ASX:PAA) In A Good Position To Deliver On Growth Plans?

This Is The Reason Why We Think PharmAust Limited's (ASX:PAA) CEO Might Be Underpaid

Oct 14
This Is The Reason Why We Think PharmAust Limited's (ASX:PAA) CEO Might Be Underpaid

What Does PharmAust's (ASX:PAA) CEO Pay Reveal?

Feb 14
What Does PharmAust's (ASX:PAA) CEO Pay Reveal?

Shareholder Returns

PAAAU PharmaceuticalsAU Market
7D4.5%-6.1%1.0%
1Y-27.4%-26.2%-2.2%

Return vs Industry: PAA underperformed the Australian Pharmaceuticals industry which returned -26.2% over the past year.

Return vs Market: PAA underperformed the Australian Market which returned -2.2% over the past year.

Price Volatility

Is PAA's price volatile compared to industry and market?
PAA volatility
PAA Average Weekly Movement6.8%
Pharmaceuticals Industry Average Movement10.2%
Market Average Movement8.9%
10% most volatile stocks in AU Market15.9%
10% least volatile stocks in AU Market4.1%

Stable Share Price: PAA is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: PAA's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/aRoger Astonhttps://www.pharmaust.com

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer.

PharmAust Limited Fundamentals Summary

How do PharmAust's earnings and revenue compare to its market cap?
PAA fundamental statistics
Market CapAU$22.07m
Earnings (TTM)-AU$1.71m
Revenue (TTM)AU$4.51m

4.9x

P/S Ratio

-12.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PAA income statement (TTM)
RevenueAU$4.51m
Cost of RevenueAU$314.34k
Gross ProfitAU$4.20m
Other ExpensesAU$5.90m
Earnings-AU$1.71m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0053
Gross Margin93.03%
Net Profit Margin-37.87%
Debt/Equity Ratio2.7%

How did PAA perform over the long term?

See historical performance and comparison